Massimo Offidani

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 20

Top Venues

Cancers

EJHaem

Pharmaceuticals (Basel, Switzerland)

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Francesca Fazio, Maria Teresa Petrucci, Laura Corvatta, Alfonso Piciocchi, Roberta Della Pepa, Paola Tacchetti, Maurizio Musso, Renato Zambello, Angelo Belotti, Sara Bringhen, Elisabetta Antonioli, Concetta Conticello, Nicola Di Renzo, Valerio De Stefano, Pellegrino Musto, Barbara Gamberi, Daniele Derudas, Mario Boccadoro, Massimo Offidani, Sonia Morè
Belantamab mafodotin in triple-refractory multiple myeloma patients: A retro-prospective observational study in Italy. EJHaem 5 (3) (2024)
Enrica Antonia Martino, Salvatore Palmieri, Monica Galli, Daniele Derudas, Roberto Mina, Roberta Della Pepa, Renato Zambello, Ernesto Vigna, Antonella Bruzzese, Silvia Mangiacavalli, Elena Zamagni, Catello Califano, Maurizio Musso, Concetta Conticello, Claudio Cerchione, Giuseppe Mele, Nicola Di Renzo, Massimo Offidani, Giuseppe Tarantini, Gloria Margiotta Casaluci, Angela Rago, Roberto Ria, Giuseppina Uccello, Gregorio Barilà, Gaetano Palumbo, Loredana Pettine, Iolanda Donatella Vincelli, Marino Brunori, Fabrizio Accardi, Valeria Amico, Angela Amendola, Raffaele Fontana, Velia Bongarzoni, Bernardo Rossini, Emilia Cotzia, Alessandro Gozzetti, Rita Rizzi, Nicola Sgherza, Giovanni Reddiconto, Antonio Maroccia, Luca Franceschini, Giuseppe Bertuglia, Davide Nappi, Emiliano Barbieri, Barbara Gamberi, Maria Teresa Petrucci, Francesco Di Raimondo, Antonino Neri, Fortunato Morabito, Pellegrino Musto, Massimo Gentile
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended follow-up of a multicenter, retrospective real-world experience with 321 cases outside of controlled clinical trials. Hematological oncology 42 (4) (2024)
Francesca Fazio, Maria Teresa Petrucci, Laura Corvatta, Alfonso Piciocchi, Roberta Della Pepa, Paola Tacchetti, Maurizio Musso, Renato Zambello, Angelo Belotti, Sara Bringhen, Elisabetta Antonioli, Concetta Conticello, Nicola Di Renzo, Valerio De Stefano, Pellegrino Musto, Barbara Gamberi, Daniele Derudas, Mario Boccadoro, Massimo Offidani, Sonia Morè
Belantamab mafodotin in triple-refractory multiple myeloma patients: A retro-prospective observational study in Italy. EJHaem 5 (3) (2024)
Enrica Antonia Martino, Salvatore Palmieri, Monica Galli, Daniele Derudas, Roberto Mina, Roberta Della Pepa, Renato Zambello, Ernesto Vigna, Antonella Bruzzese, Silvia Mangiacavalli, Elena Zamagni, Catello Califano, Maurizio Musso, Concetta Conticello, Claudio Cerchione, Giuseppe Mele, Nicola Di Renzo, Massimo Offidani, Giuseppe Tarantini, Gloria Margiotta Casaluci, Angela Rago, Roberto Ria, Giuseppina Uccello, Gregorio Barilà, Gaetano Palumbo, Loredana Pettine, Iolanda Donatella Vincelli, Marino Brunori, Fabrizio Accardi, Valeria Amico, Angela Amendola, Raffaele Fontana, Velia Bongarzoni, Bernardo Rossini, Emilia Cotzia, Alessandro Gozzetti, Rita Rizzi, Nicola Sgherza, Giovanni Reddiconto, Antonio Maroccia, Luca Franceschini, Giuseppe Bertuglia, Davide Nappi, Emiliano Barbieri, Barbara Gamberi, Maria Teresa Petrucci, Francesco Di Raimondo, Antonino Neri, Fortunato Morabito, Pellegrino Musto, Massimo Gentile
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended follow-up of a multicenter, retrospective real-world experience with 321 cases outside of controlled clinical trials. Hematological oncology 42 (4) (2024)
Sonia Morè, Laura Corvatta, Valentina Maria Manieri, Erika Morsia, Massimo Offidani
The Challenging Approach to Multiple Myeloma: From Disease Diagnosis and Monitoring to Complications Management. Cancers 16 (12) (2024)
Sonia Morè, Laura Corvatta, Valentina Maria Manieri, Erika Morsia, Massimo Offidani
The Challenging Approach to Multiple Myeloma: From Disease Diagnosis and Monitoring to Complications Management. Cancers 16 (12) (2024)
Francesca Fazio, Maria Teresa Petrucci, Laura Corvatta, Alfonso Piciocchi, Roberta Della Pepa, Paola Tacchetti, Maurizio Musso, Renato Zambello, Angelo Belotti, Sara Bringhen, Elisabetta Antonioli, Concetta Conticello, Nicola Di Renzo, Valerio De Stefano, Pellegrino Musto, Barbara Gamberi, Daniele Derudas, Mario Boccadoro, Massimo Offidani, Sonia Morè
Belantamab mafodotin in triple-refractory multiple myeloma patients: A retro-prospective observational study in Italy. EJHaem 5 (3) (2024)
Sonia Morè, Laura Corvatta, Valentina Maria Manieri, Attilio Olivieri, Massimo Offidani
Current Main Topics in Multiple Myeloma. Cancers 15 (8) (2023)
Sonia Morè, Massimo Offidani, Laura Corvatta, Maria Teresa Petrucci, Francesca Fazio
Belantamab Mafodotin: From Clinical Trials Data to Real-Life Experiences. Cancers 15 (11) (2023)
Sonia Morè, Laura Corvatta, Valentina Maria Manieri, Attilio Olivieri, Massimo Offidani
Current Main Topics in Multiple Myeloma. Cancers 15 (8) (2023)
Sonia Morè, Laura Corvatta, Maria Valentina Manieri, Attilio Olivieri, Massimo Offidani
Real-world assessment of treatment patterns and outcomes in patients with relapsed-refractory multiple myeloma in an Italian haematological tertiary care centre. British journal of haematology (2023)
Sonia Morè, Laura Corvatta, Valentina Maria Manieri, Erika Morsia, Antonella Poloni, Massimo Offidani
Novel Immunotherapies and Combinations: The Future Landscape of Multiple Myeloma Treatment. Pharmaceuticals (Basel, Switzerland) 16 (11) (2023)
Sonia Morè, Laura Corvatta, Valentina Maria Manieri, Francesco Saraceni, Ilaria Scortechini, Giorgia Mancini, Alessandro Fiorentini, Attilio Olivieri, Massimo Offidani
Autologous Stem Cell Transplantation in Multiple Myeloma: Where Are We and Where Do We Want to Go? Cells 11 (4) (2022)
Massimo Offidani, Sonia Morè, Laura Corvatta
Maintenance therapy in multiple myeloma: Two is not always better than one. British journal of haematology (2022)
Serena Rupoli, Alessandro Fiorentini, Erika Morsia, Gianluca Svegliati-Baroni, Giorgia Micucci, Luca Maroni, Kimberly Blaine Garvey, Alessandro Fiorentini, Alessandra Riva, Lidia Da Lio, Antonio Benedetti, Massimo Offidani, Attilio Olivieri, Tarantino Giuseppe
Anticoagulation and Vessel Recanalization in Cirrhotic Patients with Splanchnic Vein Thrombosis: A Multidisciplinary "Real Life" Experience. Vascular health and risk management 17 (2021)
Pieter Sonneveld, Meletios- Athanasios Dimopoulos, Meral Beksac, Bronno van der Holt, Sara Aquino, Heinz Ludwig, Sonja Zweegman, Thilo Zander, Elena Zamagni, Ruth Wester, Roman Hajek, Lucia Pantani, Luca Dozza, Francesca Gay, AnneMaria Cafro, Luca De Rosa, Annamaria Morelli, Henrik Gregersen, Nina Gulbrandsen, Petra Cornelisse, Rosella Troia, Stefania Oliva, Vincent H J van der Velden, Ka Lung Wu, Paula F Ypma, Gerard M J Bos, Mark-David Levin, Luca Pour, Christoph Driessen, Annemiek Broijl, Alexandra Croockewit, Monique C Minnema, Anders Waage, Cecilie Hveding Blimark, Niels W C J van de Donk, Massimo Offidani, Giuseppe Alberto Maria Palumbo, Andrew Spencer, Mario Boccadoro, Michele Cavo
Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (32) (2021)
Massimo Offidani, Laura Corvatta, Sonia Morè, Attilio Olivieri
Novel Experimental Drugs for Treatment of Multiple Myeloma. Journal of experimental pharmacology 13 (2021)
Massimo Offidani, Laura Corvatta, Sonia Morè, Attilio Olivieri
Belantamab Mafodotin for the Treatment of Multiple Myeloma: An Overview of the Clinical Efficacy and Safety. Drug design, development and therapy 15 (2021)
Massimo Offidani, Maria Teresa Petrucci
Introduction to "Immunotherapies for Multiple Myeloma". Pharmaceuticals (Basel, Switzerland) 13 (11) (2020)
Sonia Morè, Maria Teresa Petrucci, Laura Corvatta, Francesca Fazio, Massimo Offidani, Attilio Olivieri
Monoclonal Antibodies: Leading Actors in the Relapsed/Refractory Multiple Myeloma Treatment. Pharmaceuticals (Basel, Switzerland) 13 (12) (2020)

Massimo Offidani.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Massimo Offidani